CA2992174C - Compositions de combinaisons pour le traitement de troubles necessitant le retrait ou la destruction de proliferations cellulaires non voulues - Google Patents

Compositions de combinaisons pour le traitement de troubles necessitant le retrait ou la destruction de proliferations cellulaires non voulues

Info

Publication number
CA2992174C
CA2992174C CA2992174A CA2992174A CA2992174C CA 2992174 C CA2992174 C CA 2992174C CA 2992174 A CA2992174 A CA 2992174A CA 2992174 A CA2992174 A CA 2992174A CA 2992174 C CA2992174 C CA 2992174C
Authority
CA
Canada
Prior art keywords
leu
peptide
ser
arg
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2992174A
Other languages
English (en)
Other versions
CA2992174A1 (fr
Inventor
Paul Averback
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/738,551 external-priority patent/US20160361380A1/en
Application filed by Nymox Corp filed Critical Nymox Corp
Publication of CA2992174A1 publication Critical patent/CA2992174A1/fr
Application granted granted Critical
Publication of CA2992174C publication Critical patent/CA2992174C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Les modes de réalisation de l'invention comprennent des méthodes de traitement d'affections nécessitant le retrait ou la destruction d'éléments cellulaires, tels que des tumeurs bénignes ou malignes, à l'aide de composés à base de petits peptides combinés à un ou plusieurs principes actifs supplémentaires. Ladite méthode comprend, mais sans y être limitée, une étape d'administration desdits composés par voie intramusculaire, orale, intraveineuse, intrathécale, intraprostatique, intratumorale, intranasale, topique, transdermique, etc. soit seuls, soit conjugués à un excipient, à un mammifère nécessitant un tel traitement.
CA2992174A 2015-06-12 2016-06-13 Compositions de combinaisons pour le traitement de troubles necessitant le retrait ou la destruction de proliferations cellulaires non voulues Active CA2992174C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/738,551 2015-06-12
US14/738,551 US20160361380A1 (en) 2015-06-12 2015-06-12 Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
PCT/IB2016/053483 WO2016199112A1 (fr) 2015-06-12 2016-06-13 Compositions de combinaisons pour le traitement de troubles nécessitant le retrait ou la destruction de proliférations cellulaires non voulues

Publications (2)

Publication Number Publication Date
CA2992174A1 CA2992174A1 (fr) 2016-12-15
CA2992174C true CA2992174C (fr) 2025-08-12

Family

ID=

Similar Documents

Publication Publication Date Title
AU2016275368B2 (en) Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
EP3324994B1 (fr) Nx-1207 pour l'utilisations dans des méthodes de réduction de la nécessité d'une chirurgie chez des patients atteints d'hyperplasie bénigne de la prostate
AU2017283820B2 (en) Neural thread peptide for preventing or reducing the progression of prostate cancer
AU2017325033B2 (en) Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
AU2017304100B2 (en) Method of preventing or reducing the incidence of acute urinary retention
HK1254080B (en) Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
HK1249007B (en) Nx-1207 for use in methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
HK1260762A1 (en) Neural thread peptide for preventing or reducing the progression of prostate cancer
HK1260762B (en) Neural thread peptide for preventing or reducing the progression of prostate cancer
HK40005180B (en) Ntp peptides for use in preventing or reducing the incidence of acute urinary retention
HK40017931A (en) Fexapotid for improving sexual function